Medical
Orgenesis Advances Accessibility in Cell and Gene Therapies
Orgenesis Inc. (OTCQX: ORGS), a global biotech company has recently shared its business update for the third quarter ending September 30, 2024. The company is...
HPQ Silicon Advances Fumed Silica Reactor Project Towards Commercial Production
HPQ Silicon Inc. (trading (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08) is making significant strides in the development of its proprietary Fumed Silica Reactor (FSR) technology,...
Cresco Labs Reports Strong Financial Performance in Q3 2024: A Testament to Cash Flow Strategy
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ), a leading name in the branded cannabis market and operator of Sunnyside dispensaries, has announced its...
Emerging Laser Technologies and the Future of Medicine
The landscape of medical treatment is undergoing a significant transformation, largely driven by advancements in laser technology. Lasers, which were once primarily confined to niche...
Gabelli Funds and Columbia Business School Collaborate for 6th Annual Healthcare Symposium
Gabelli Funds, LLC, in collaboration with Columbia Business School, is set to host the 6th Annual Healthcare Symposium on November 15, 2024, at the Paley...
InHouse by MariMed Launches Initiative to Assist Veterans with Housing Challenges
In a significant move to support veterans facing housing difficulties, InHouse™, a brand under MariMed Inc. (CSE: MRMD, OTCQX: MRMD), has announced the launch of...
Orexo AB Launches New Study of OX640 for Treating Allergic Rhinitis
Orexo AB (STO: ORX, OTCQX: ORXOY), a Sweden-based pharmaceutical company, announced today the initiation of a new clinical study for its intranasal medication, OX640, targeting...
Piper Sandler Reaffirms Tango Therapeutics’ Stock Overweight Rating Amid Drug Pipeline Developments
Tango Therapeutics Stock : Analyst Confidence Stays Strong Piper Sandler has reaffirmed its Overweight rating for Tango Therapeutics Inc stock(NASDAQ: TNGX). The price target remains...
Positive Interim Data Drives Centessa Pharmaceuticals’ Stock Surge
Positive Trial Data Propels Centessa Shares Higher – Centessa Pharmaceuticals plc (NASDAQ: CNTA) is gaining attention in the stock market with its recent press release....
SINTX Technologies Shares Surge 91% on Patent Approval, Then Correct; What’s Next for Investors?
Patent Approval Sparks SINTX Technologies Shares Surge SINTX Technologies Inc (SINT) saw a dramatic 91.5% surge in its shares price to $5.40 on Monday. However,...
